ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
Risk Signals
24752 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Business Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ROCHE DIAGNOSTICS LIMITED
Live alerts from global media, monitored by Business Radar
2025-04-08 (businesstoday.in)
Natco Pharma shares legal update on Risdiplam patent; stock up 3% - Natco Pharma shares legal update on Risdiplam patent; stock up 3% BusinessToday
Natco Pharma share price: The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, it has crashed 44.42 per cent on a year-to-date (YTD) basis.
Read more
2023-03-01 (bioprocessintl.com)
Facilities do not always begin with bricks, Genentech - BioProcess insider
The buildout of a facility ends with technology choices but starts with a purpose, vision, and people, says Roche’s Genentech.
Read more
2022-10-19 (bioprocessintl.com)
J&J and Roche feeling the biosimilar bite in Q3 - BioProcess Insider
Both J&J and Roche are feeling pressure from biosimilars as sales of blockbuster products such as Remicade and Lucentis drop in Q3.
Read more
2019-08-16 (swissinfo.ch)
Swiss pharma executive gets US sanction for insider trading
The US Securities and Exchange Commission has fined Lorenz Erne, a former senior executive at Swiss pharmaceutical firm Roche, for insider trading.
Read more
2019-08-16 (swissinfo.ch)
Swiss pharma executive gets US sanction for insider trading
The US Securities and Exchange Commission has fined Lorenz Erne, a former senior executive at Swiss pharmaceutical firm Roche, for insider trading.
Read more